Authored and contributed to PharmaLeaders by Michelle Marlborough, Chief Product Officer, AiCure, LLC Machine learning (ML) innovation for clinical research holds great promise for improving drug development and patient care. But, like with all new technology, increasing prevalence can be accompanied by growing skepticism. Pharmaceutical sponsors and clinicians are … [Read more...]
How can pharmaceutical corporations successfully collaborate with tech startups?
Article contributed by: Tristan Salomon, founder and CEO of Axom, and expert in Machine Learning, Big Data and AI. Any business needs to possess top-level technological advances not just to stand out from, but at least to keep up with the competition. This is especially true for pharmaceutical companies. The current pandemic situation has tested them on the ability to … [Read more...]
This is how XR technology is transforming medical device training
Article contributed and authored by: Dr. Alex Young, NHS surgeon and founder of Virti It’s estimated by the World Health Organisation (WHO) that there are more than 2 million different kinds of medical devices in the global market, ranging from surgical instruments to wound care apparatus and diagnostic software. Without them, modern medical practice as we know it would be … [Read more...]
How to use digital platforms to engage with your customers
Article contributed to PharmaLeaders by Rachel Murray, Head of Partnerships, Fountain Partnership The last year has seen the Pharma industry propelled into the digital world in order to deliver clear communication to healthcare professionals and customers. Traditionally reliant on face-to-face communication, including selling, the Covid-19 pandemic has accelerated online … [Read more...]
How Natural Language Processing Unlocks the Full Healthcare and Patient Journey
Contributed to PharmaLeaders by Authors: By Ana Bargo, M.S.; Jeannine Cain, MSHI, RHIA, CPHI; Shannon Fee, B.A.; Mark Yap, FNP-C In 2016, a major transformation occurred in how we evaluate clinical data for real-world effectiveness. The FDA signed into law the 21st Century Cures Act, which impacted the Real-World Evidence Program in the U.S. It signaled a paradigm shift in … [Read more...]